Funds holding CG oncology Inc
305 funds declare a position · 55 ETFs and 250 other funds · 2.2B $· 13.3M SEK· 19.8K € · US1569441009
Each line carries its report date.
| Rank | Fund | Shares | Value | Weight | |
|---|---|---|---|---|---|
| 301 | Columbia Research Enhanced Small Cap ETF Columbia ETF Trust I | 45 | 3K $ | 0.10 % | as of Mar 31, 2026 · Original filing |
| 302 | Goldman Sachs MSCI World Private Equity Return Tracker ETF Goldman Sachs ETF Trust | 26 | 1.5K $ | 0.01 % | as of Feb 28, 2026 · Original filing |
| 303 | ProShares Russell 2000 Dynamic Buffer ETF ProShares Trust | 18 | 1.1K $ | 0.09 % | as of Feb 28, 2026 · Original filing |
| 304 | Russell 2000(R) 1.5x Strategy Fund Rydex Variable Trust | 15 | 1K $ | 0.04 % | as of Mar 31, 2026 · Original filing |
| 305 | A&P LIFESCIENCE FUND, FI WELZIA MANAGEMENT, SGIIC, S.A. | 19.8K € | 0.54 % | as of Dec 31, 2025 · Original filing |
Institutional managers
227 managers declare this company to the SEC (Form 13F). These positions are not counted in the totals above: a manager and its own funds file separately.
| Manager | Shares | Value | |
|---|---|---|---|
| RTW INVESTMENTS, LP | 6,984,808 | 472.7M $ | as of Mar 31, 2026 |
| Decheng Capital LLC | 6,371,669 | 431.2M $ | as of Mar 31, 2026 |
| WELLINGTON MANAGEMENT GROUP LLP | 5,371,232 | 363.5M $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 5,064,180 | 342.7M $ | as of Mar 31, 2026 |
| FMR LLC | 3,764,844 | 254.8M $ | as of Mar 31, 2026 |
| TCG Crossover Management, LLC | 3,670,206 | 248.4M $ | as of Mar 31, 2026 |
| STATE STREET CORP | 2,647,054 | 179.2M $ | as of Mar 31, 2026 |
| Foresite Capital Management VI LLC | 2,221,474 | 150.3M $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 1,596,864 | 108.1M $ | as of Mar 31, 2026 |
| FRANKLIN RESOURCES INC | 1,507,005 | 102M $ | as of Mar 31, 2026 |
| BANK OF AMERICA CORP /DE/ | 1,449,364 | 98.1M $ | as of Mar 31, 2026 |
| DV Trading LLC | 1,439,393 | 97.4M $ | as of Mar 31, 2026 |
| UBS Group AG | 1,311,978 | 88.8M $ | as of Mar 31, 2026 |
| Avidity Partners Management LP | 1,288,948 | 87.2M $ | as of Mar 31, 2026 |
| GOLDMAN SACHS GROUP INC | 1,159,239 | 78.5M $ | as of Mar 31, 2026 |
| ACORN CAPITAL ADVISORS, LLC | 1,130,501 | 76.6M $ | as of Mar 31, 2026 |
| EcoR1 Capital, LLC | 1,102,000 | 74.6M $ | as of Mar 31, 2026 |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 1,064,966 | 72.1M $ | as of Mar 31, 2026 |
| Foresite Capital Management V, LLC | 1,004,050 | 68M $ | as of Mar 31, 2026 |
| Driehaus Capital Management LLC | 999,623 | 67.7M $ | as of Mar 31, 2026 |
| BRAIDWELL LP | 984,783 | 66.7M $ | as of Mar 31, 2026 |
| ORBIMED ADVISORS LLC | 948,267 | 64.2M $ | as of Mar 31, 2026 |
| ALLIANCEBERNSTEIN L.P. | 1,290,087 | 53.6M $ | as of Mar 31, 2026 |
| Clearbridge Investments, LLC | 730,283 | 49.4M $ | as of Mar 31, 2026 |
| Polar Capital Holdings Plc | 704,461 | 47.7M $ | as of Mar 31, 2026 |